[VRTX] YoY Quarter Result on 30-Sep-2009 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
09-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- 12.69%
YoY- -15.01%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Revenue 336,006 659,200 23,795 24,957 31,609 41,014 53,289 35.88%
PBT -5,112 200,610 -208,957 -149,565 -130,044 -107,033 -51,802 -31.99%
Tax 21,355 -27,842 3,477 -4,709 301 -5,880 -8,910 -
NP -57,543 221,110 -208,957 -149,565 -130,044 -107,033 -51,802 1.76%
Tax Rate - 13.88% - - - - - -
Total Cost 393,549 438,090 232,752 174,522 161,653 148,047 105,091 24.59%
Ratio Analysis
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
NP Margin -17.13 33.54 -878.16 -599.29 -411.41 -260.97 -97.21 -25.10%
Per Share
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
EPS -0.27 1.06 -1.04 -0.84 -0.93 -0.82 -0.46 -8.48%
EPS Diluted -0.27 1.02 -1.04 -0.84 -0.93 -0.82 -0.46 -8.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.